Literature DB >> 26898986

Screening for hepatocellular carcinoma in high-risk populations.

Zoe A Miller1, Kyungmouk Steve Lee2.   

Abstract

Screening for hepatocellular carcinoma (HCC) should be implemented in the high-risk population. High-risk population includes patients with cirrhosis of any etiology, patients with chronic hepatitis B virus with or without cirrhosis, and patients with chronic hepatitis C virus with cirrhosis. A randomized controlled trial of over 18,000 high-risk individuals demonstrated that biannual screening reduced HCC-related mortality by 37%. The screening test of choice is ultrasound imaging with an interval of 6 months.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Hepatitis B; Hepatitis C; Hepatocellular carcinoma screening; Liver cancer screening

Mesh：

Year:  2015        PMID： 26898986     DOI： 10.1016/j.clinimag.2015.11.010

Source DB:  PubMed          Journal:  Clin Imaging        ISSN： 0899-7071            Impact factor:   1.605


  7 in total

1.  LncRNA LINC00460 takes a stimulating role on hepatocellular carcinoma stemness property.

Authors:  Bitao Chen; Kejun Zhang; Qinli Han; Weiwei Zhong; Jie Yi; Huiling Zhu; Shitao Xia
Journal:  Cell Cycle       Date:  2021-10-06       Impact factor: 5.173

Review 2.  Application of new ultrasound techniques for focal liver lesions.

Authors:  Feiqian Wang; Kazushi Numata; Hiromi Nihonmatsu; Masahiro Okada; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2020-01-16       Impact factor: 1.314

3.  Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Akash Shukla; Ananta Shreshtha; Amar Mukund; Chhagan Bihari; C E Eapen; Guohong Han; Hemant Deshmukh; Ian Homer Y Cua; Cosmas Rinaldi Adithya Lesmana; Mamun Al Meshtab; Masayoshi Kage; Roongruedee Chaiteeraki; Sombat Treeprasertsuk; Suprabhat Giri; Sundeep Punamiya; Valerie Paradis; Xingshun Qi; Yasuhiko Sugawara; Zaigham Abbas; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-07-08       Impact factor: 6.047

Review 4.  Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Stijn Van Hees; Peter Michielsen; Thomas Vanwolleghem
Journal:  World J Gastroenterol       Date:  2016-10-07       Impact factor: 5.742

5.  Signal Transducer and Activator of Transcription 3 for the Differentiation of Hepatocellular Carcinoma from Cirrhosis.

Authors:  Yan-Ping Li; Wen-Ze Wang; Xue-Qi Chen; Ling-Bo Li; Zhi-Yong Liang; Kun Ru; Jing-Nan Li
Journal:  Chin Med J (Engl)       Date:  2017-11-20       Impact factor: 2.628

Review 6.  Screening, Surveillance, and Management of Hepatocellular Carcinoma During the COVID-19 Pandemic: a Narrative Review.

Authors:  Sami Akbulut; Ibrahim Umar Garzali; Abdirahman Sakulen Hargura; Ali Aloun; Sezai Yilmaz
Journal:  J Gastrointest Cancer       Date:  2022-05-02

7.  Risk factors for early postoperative recurrence in single and small hepatitis B virus-associated primary hepatocellular carcinoma.

Authors:  Hongmei Jin; Hui Wang; Guanghao Li; Qingshun Hou; Wei Wu; Fuhui Liu
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.